Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Suneel Gupta currently holds 93,750 shares of Protagonist Therapeutics, Inc (PTGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Suneel Gupta has been a net buyer of PTGX stock. They have purchased $153.9K and sold $125.0K worth of shares.
Suneel Gupta's most recent insider trade was on Nov 26, 2024, when they sold 30,000 shares at $0.00 per share.
Suneel Gupta serves as Executive at Protagonist Therapeutics, Inc (PTGX). They have executed 21 insider transactions totaling $278.9K over their tenure at the company.
Suneel Gupta holds the position of Executive at Protagonist Therapeutics, Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Suneel Gupta has shown a buying trading pattern, with $153.9K in total purchases and $125.0K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Suneel Gupta was on Apr 26, 2022, when they sold $295.2K worth of PTGX shares. This transaction involved 40,000 shares at $7.38 per share.
Suneel Gupta currently owns 93,750 shares of Protagonist Therapeutics, Inc (PTGX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Suneel Gupta's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Suneel Gupta has 21 Form 4 filings on record as an insider at Protagonist Therapeutics, Inc.
Set alerts for Suneel Gupta and 40,000+ other insiders.